64B16-26.300: Consultant Pharmacist Licensure
PURPOSE AND EFFECT: The Board proposes the rule amendment to modify the training skills required for licensure as a Consultant Pharmacist.
SUMMARY: The rule amendment will modify the training skills required for licensure as a Consultant Pharmacist.
SUMMARY OF ESTIMATED REGULATORY COSTS: No Statement of Estimated Regulatory Cost was prepared.
Any person who wishes to provide information regarding a statement of estimated regulatory costs, or provide a proposal for a lower cost regulatory alternative must do so in writing within 21 days of this notice.
SPECIFIC AUTHORITY: 465.005, 465.0125 FS.
LAW IMPLEMENTED: 465.0125 FS.
IF REQUESTED WITHIN 21 DAYS OF THE DATE OF THIS NOTICE, A HEARING WILL BE SCHEDULED AND ANNOUNCED IN FAW.
THE PERSON TO BE CONTACTED REGARDING THE PROPOSED RULE IS: Rebecca R. Poston, Executive Director, Board of Pharmacy/MQA, 4052 Bald Cypress Way, Bin #C04, Tallahassee, Florida 32399-3253.
THE FULL TEXT OF THE PROPOSED RULE IS:
64B16-26.300 Consultant Pharmacist Licensure
(1) through (2)(b) No change.
(c) Successfully complete a period of assessment and evaluation under the supervision of a preceptor within one (1) year of completion of the course set forth in paragraph (b) above. This period of assessment and evaluation shall be completed over no more than three (3) consecutive months and shall include at least 40 hours of training in the following practice areas, 60% of which shall occur on-site at an institution that holds a pharmacy permit. The training shall include:
Minimum Skill Required Percent of Time Hours
|
Minimum of 40 Hours in Maximum of Three Months 1. Regimen review, documentation and communication. a. Demonstrate ability to carry out process and understand documentation functions. b. Understand and perform drug regimen review. Communicate findings to appropriate individuals or groups. c. The Consultant pharmacist is responsible for learning other skills needed to perform in his/her type of facility where he/she is or will be the consultant Pharmacist of Record. 2. Facility review. Demonstrate areas that should be evaluated, documentation, and reporting procedures. 3. Committee and Reports. Review 4. through 6. No change.
(3) through (7) No change.
|
5% |
2 |
Specific Authority 465.005, 465.0125 F.S. Law Implemented 465.0125 F.S. History-New 5-19-72, Revised 4-19-74, Repromulgated 12-18-74, Amended 10-17-79, 4-8-80, 7-29-81, 7-1-83, 4-10-84, 4-30-85, Formerly 21S-1.26, 21S-1.026, Amended 7-31-91, 10-14-91, Formerly 21S-26.300, 61F10-26.300, Amended 9-19-94, 3-28-95, 3-10-96, Formerly 59X-26.300, Amended 5-22-01, 5-5-05, .